BCRX press release
RTPR•21/10/2026•16:01 ET
0
Key Highlights
- ➤BioCryst will report third quarter 2026 financial results November 4, 2026
- ➤Management will host an 8:30 a.m. ET results conference call and webcast
- ➤ORLADEYO remains BioCryst’s commercialized oral, once-daily plasma kallikrein inhibitor
RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial results on Wednesday, November 4, 2026.
BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.
Get started
Create a free account to read the full story.